Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4+ T-cell tolerance

Hongwei Wang, Fengdong Cheng, Alex Cuenca, Pedro Horna, Zheng Zheng, Kapil Bhalla, Eduardo M. Sotomayor

Research output: Contribution to journalArticlepeer-review

81 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib mesylate (STI-571) enhances antigen-presenting cell function and overcomes tumor-induced CD4<sup>+</sup> T-cell tolerance'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds